KURA FY 2021 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$815M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$131M

Net Income

-$130M

EPS (Diluted)

$-1.97

Cash Flow

Operating Cash Flow

-$105M

Free Cash Flow

-$106M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$534M

Total Liabilities

$27M

Stockholders' Equity

$507M

Cash & Equivalents

$91M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$194,000	+100.0%
Operating Income	-$131M	-$92M	-42.8%
Net Income	-$130M	-$90M	-45.6%